Immunotoxicity refers to the adverse effects of chemical substances, drugs, environmental pollutants, or biological agents on the immune system. These substances can disrupt the normal functioning of the immune system, leading to immune dysregulation, impaired immune responses, and increased susceptibility to infections, autoimmune diseases, allergies, or cancer. Chemical substances with immunotoxic properties include pharmaceutical drugs, industrial chemicals, pesticides, heavy metals, solvents, and environmental pollutants. Exposure to these substances can occur through various routes, including ingestion, inhalation, dermal contact, or injection, and can result in immune suppression, immunosuppression, or immune activation, depending on the nature and dose of the toxicant. Pharmaceutical drugs, such as chemotherapeutic agents, immunosuppressant, and biologic therapies, are known to have immunotoxic effects due to their interactions with immune cells, cytokines, and signalling pathways. These drugs may suppress immune responses to prevent rejection of transplanted organs or treat autoimmune diseases but can also increase the risk of infections or secondary malignancies by compromising immune function. Environmental pollutants, such as air pollutants, heavy metals, pesticides, and industrial chemicals, can also exert immunotoxic effects by disrupting immune cell function, cytokine production, and immune signalling pathways.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States